AGGRASTAT
Google image searchProduct monograph
Active ingredient
tirofiban (tirofiban hydrochloride), 12.5 MG/250 ML
DIN: 02240706
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: CIPHER PHARMACEUTICALS INC
Date: 29-JUL-2021
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AC — Platelet aggregation inhibitors excl. heparin (ATC, ATC/DDD)
- B01AC17 — TIROFIBAN (ATC/DDD)
Reference brand drug: Aggrastat
Pharmaceutical standard: MFR